scholarly article | Q13442814 |
P50 | author | Kelly K Hunt | Q90520703 |
Judy Boughey | Q92381506 | ||
Reshma Jagsi | Q38545755 | ||
P2093 | author name string | Thomas A Buchholz | |
Bruce G Haffty | |||
Karla V Ballman | |||
David W Ollila | |||
Sarah McLaughlin | |||
Linda M McCall | |||
P2860 | cites work | Breast Cancer Version 2.2015. | Q53546077 |
Using Chemotherapy Response to Personalize Choices Regarding Locoregional Therapy: A New Era in Breast Cancer Treatment? | Q57304472 | ||
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 | Q77438388 | ||
Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction | Q86872116 | ||
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial | Q95722875 | ||
Neoadjuvant therapy in the treatment of breast cancer | Q27694514 | ||
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. | Q34158197 | ||
Radiation field design in the ACOSOG Z0011 (Alliance) Trial | Q34451764 | ||
Regional Nodal Irradiation in Early-Stage Breast Cancer | Q34486386 | ||
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial | Q34919537 | ||
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy | Q35087084 | ||
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. | Q36368893 | ||
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference | Q37079615 | ||
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease | Q37079625 | ||
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013). | Q37228051 | ||
Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review | Q37246608 | ||
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting. | Q37633169 | ||
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer | Q38009526 | ||
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies | Q38263152 | ||
Radiotherapy Issues After Neoadjuvant Chemotherapy | Q40847134 | ||
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer | Q41103003 | ||
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer | Q41558949 | ||
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation | Q43843446 | ||
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. | Q44648834 | ||
Nationwide trends in mastectomy for early-stage breast cancer | Q44729377 | ||
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. | Q46765380 | ||
The evolution of regional nodal irradiation in breast cancer | Q48059157 | ||
Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy. | Q53471110 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 493-502 | |
P577 | publication date | 2015-11-10 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). | |
P478 | volume | 94 |
Q57117791 | Breast cancer |
Q88501523 | Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice |
Q64109095 | Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial |
Q37126030 | Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer |
Q46304850 | Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice |
Q90376518 | Patterns of post-operative irradiation in breast cancer patients submitted to neoadjuvant chemotherapy |
Q37547957 | Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy |
Q91845083 | Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy |
Q33889349 | Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy |